Xun Zhu
Director/Board Member at SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Net worth: 750 926 $ as of 2024-04-29
Xun Zhu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Director/Board Member | 2014-02-19 | - |
| Independent Dir/Board Member | 2014-02-19 | - | |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Director/Board Member | 2018-03-23 | - |
| Independent Dir/Board Member | 2018-03-23 | - | |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Director/Board Member | 2022-09-22 | - |
| Independent Dir/Board Member | 2022-09-22 | - | |
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 2020-11-29 | - |
| Cathay International Pharmaceutical Ltd. | Director/Board Member | 2011-07-31 | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - | - |
| Norman Bethune Medical University | Corporate Officer/Principal | 1994-12-31 | - |
| National Natural Science Foundation of China | Corporate Officer/Principal | - | - |
Career history of Xun Zhu
Former positions of Xun Zhu
| Companies | Position | Start | End |
|---|---|---|---|
| Jilin University | Corporate Officer/Principal | 1994-07-31 | 2018-05-31 |
| ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Training of Xun Zhu
| Norman Bethune Medical University | Doctorate Degree |
Statistics
International
| China | 7 |
| Cayman Islands | 4 |
Operational
| Director/Board Member | 6 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Government | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Cathay International Pharmaceutical Ltd. | |
| China Medicinal Biotech Association | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
| National Natural Science Foundation of China | Government |
- Stock Market
- Insiders
- Xun Zhu
- Experience
